GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 320 filers reported holding GW PHARMACEUTICALS PLC in Q4 2019. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $9,414,000 | +93.4% | 81,573 | +63.1% | 2.41% | +87.1% |
| Q3 2020 | $4,868,000 | -66.9% | 50,000 | -58.3% | 1.29% | -68.9% |
| Q2 2020 | $14,699,000 | +36.7% | 119,778 | -2.4% | 4.14% | -16.9% |
| Q1 2020 | $10,752,000 | +8.2% | 122,778 | +29.2% | 4.98% | +73.8% |
| Q4 2019 | $9,933,000 | – | 95,000 | – | 2.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |